{"id":"https://openalex.org/W2029477388","doi":"https://doi.org/10.1210/jc.2012-3034","title":"What Next after Metformin? A Retrospective Evaluation of the Outcome of Second-Line, Glucose-Lowering Therapies in People with Type 2 Diabetes","display_name":"What Next after Metformin? A Retrospective Evaluation of the Outcome of Second-Line, Glucose-Lowering Therapies in People with Type 2 Diabetes","alternate_titles":[],"publication_year":2012,"publication_date":"2012-10-18","ids":{"openalex":"https://openalex.org/W2029477388","doi":"https://doi.org/10.1210/jc.2012-3034","mag":"2029477388","pmid":"https://pubmed.ncbi.nlm.nih.gov/23076348"},"language":"en","primary_location":{"id":"doi:10.1210/jc.2012-3034","doi":"https://doi.org/10.1210/jc.2012-3034","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2012-3034","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2029477388"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045232687","display_name":"Christopher Ll. Morgan","orcid":"https://orcid.org/0000-0001-8796-7406","observed_orcids":["https://orcid.org/0000-0001-8796-7406"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher Ll. Morgan","raw_affiliation_strings":["Department of Primary Care and Public Health (C.L.M., C.D.P., C.J.C.), Cardiff CF14 4UJ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Primary Care and Public Health (C.L.M., C.D.P., C.J.C.), Cardiff CF14 4UJ, United Kingdom","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110770662","display_name":"Chris Poole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chris D. Poole","raw_affiliation_strings":["Department of Primary Care and Public Health (C.L.M., C.D.P., C.J.C.), Cardiff CF14 4UJ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Primary Care and Public Health (C.L.M., C.D.P., C.J.C.), Cardiff CF14 4UJ, United Kingdom","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053232051","display_name":"Marc Evans","orcid":"https://orcid.org/0000-0003-0671-0778","observed_orcids":["https://orcid.org/0000-0003-0671-0778"]},"institutions":[{"id":"https://openalex.org/I2800861664","display_name":"University Hospital of Wales","ror":"https://ror.org/04fgpet95","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1299209451","https://openalex.org/I2800861664","https://openalex.org/I4210144625"]},{"id":"https://openalex.org/I4210146878","display_name":"University Hospital Llandough","ror":"https://ror.org/05fcrn131","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1299209451","https://openalex.org/I4210144625","https://openalex.org/I4210146878"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Evans","raw_affiliation_strings":["Department of Medicine (M.E.), University Hospital of Wales, Llandough, Cardiff CF64 2XX, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine (M.E.), University Hospital of Wales, Llandough, Cardiff CF64 2XX, United Kingdom","institution_ids":["https://openalex.org/I2800861664","https://openalex.org/I4210146878"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023295361","display_name":"Anthony H Barnett","orcid":"https://orcid.org/0000-0002-6320-4073","observed_orcids":["https://orcid.org/0000-0002-6320-4073"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthony H. Barnett","raw_affiliation_strings":["Division of Clinical and Experimental Medicine (A.H.B.), University of Birmingham, and Biomedical Research Unit, Heart of England National Health Service Trust, Birmingham B9 5ST, United Kingdom; University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom","University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical and Experimental Medicine (A.H.B.), University of Birmingham, and Biomedical Research Unit, Heart of England National Health Service Trust, Birmingham B9 5ST, United Kingdom; University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041208087","display_name":"Sara Jenkins\u2010Jones","orcid":"https://orcid.org/0000-0003-3836-8102","observed_orcids":["https://orcid.org/0000-0003-3836-8102"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sara Jenkins-Jones","raw_affiliation_strings":["School of Medicine, Cardiff University, The Pharma Research Centre, and Department of Global Epidemiology (S.J.-J.), Pharmatelligence, Cardiff MediCentre, Cardiff CF14 4UJ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, Cardiff University, The Pharma Research Centre, and Department of Global Epidemiology (S.J.-J.), Pharmatelligence, Cardiff MediCentre, Cardiff CF14 4UJ, United Kingdom","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077893105","display_name":"Craig J. Currie","orcid":"https://orcid.org/0000-0002-6154-818X","observed_orcids":["https://orcid.org/0000-0002-6154-818X"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Craig J. Currie","raw_affiliation_strings":["Department of Primary Care and Public Health (C.L.M., C.D.P., C.J.C.), Cardiff CF14 4UJ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Primary Care and Public Health (C.L.M., C.D.P., C.J.C.), Cardiff CF14 4UJ, United Kingdom","institution_ids":["https://openalex.org/I79510175"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5077893105"],"corresponding_institution_ids":["https://openalex.org/I79510175"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":6.3884,"has_fulltext":false,"cited_by_count":93,"citation_normalized_percentile":{"value":0.97262283,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"97","issue":"12","first_page":"4605","last_page":"4612"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8109999895095825},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9100000262260437},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.5379999876022339},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9589999914169312},{"id":"https://openalex.org/keywords/primary-care-patients","display_name":"primary care patients","score":0.5580000281333923},{"id":"https://openalex.org/keywords/treatment-outcomes-comparison","display_name":"treatment outcomes comparison","score":0.574999988079071},{"id":"https://openalex.org/keywords/stroke-risk","display_name":"stroke risk","score":0.5699999928474426},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.5989999771118164},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.882413387298584},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.869067907333374},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6903026103973389},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.6534318923950195},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6323054432868958},{"id":"https://openalex.org/C2780739214","wikidata":"https://www.wikidata.org/wiki/Q6723023","display_name":"Mace","level":4,"score":0.6012330055236816},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.5672610998153687},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5604143142700195},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.49601373076438904},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.49433398246765137},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4455978572368622},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4397083520889282},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.42078810930252075},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.20271587371826172},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1781439185142517},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.0975741446018219},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.07934832572937012},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.0758863091468811}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1210/jc.2012-3034","doi":"https://doi.org/10.1210/jc.2012-3034","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2012-3034","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:23076348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23076348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Evaluation Study"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:43238","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/43238/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W100598291","https://openalex.org/W170432399","https://openalex.org/W172609984","https://openalex.org/W1608662320","https://openalex.org/W1975663485","https://openalex.org/W1983401438","https://openalex.org/W1994269792","https://openalex.org/W2000445173","https://openalex.org/W2003956196","https://openalex.org/W2009332711","https://openalex.org/W2039741453","https://openalex.org/W2055789597","https://openalex.org/W2064617441","https://openalex.org/W2072114549","https://openalex.org/W2081276121","https://openalex.org/W2098041009","https://openalex.org/W2107562831","https://openalex.org/W2109728760","https://openalex.org/W2110418106","https://openalex.org/W2110641080","https://openalex.org/W2120774442","https://openalex.org/W2127125241","https://openalex.org/W2128712342","https://openalex.org/W2139516278","https://openalex.org/W2139562487","https://openalex.org/W2146901298","https://openalex.org/W2159969745","https://openalex.org/W2162738851","https://openalex.org/W2163589808","https://openalex.org/W2171646682","https://openalex.org/W4242434779","https://openalex.org/W6606985554"],"related_works":["https://openalex.org/W2020388702","https://openalex.org/W2163672431","https://openalex.org/W2107166617","https://openalex.org/W2493002183","https://openalex.org/W1941032944","https://openalex.org/W2340898396","https://openalex.org/W2795022104","https://openalex.org/W3109706586","https://openalex.org/W2157836715","https://openalex.org/W4292620874"],"abstract_inverted_index":{"CONTEXT:":[0],"After":[1],"failure":[2],"of":[3,22,86,94,123,125,226],"metformin":[4,64,227,243],"monotherapy,":[5],"many":[6],"second-line,":[7,76],"glucose-lowering":[8,77],"therapies":[9],"are":[10],"available":[11],"to":[12,26,143,231],"treat":[13],"people":[14],"with":[15,58,102,237],"type":[16,59],"2":[17,60],"diabetes.":[18],"OBJECTIVE:":[19],"The":[20,224],"objective":[21],"the":[23,46,80,178,200,238],"study":[24,42,81],"was":[25,38,147],"compare":[27],"clinical":[28,144,234],"outcomes":[29,235],"using":[30,43,149],"common":[31],"alternative":[32],"regimens.":[33],"DESIGN":[34],"AND":[35],"SETTING:":[36],"This":[37],"a":[39,91,100,119],"retrospective":[40],"cohort":[41],"data":[44],"from":[45],"U.K.-based":[47],"General":[48],"Practice":[49],"Research":[50],"Database.":[51],"PATIENTS:":[52],"These":[53],"were":[54,89,98,127,132],"primary":[55],"care":[56],"patients":[57,88],"diabetes":[61],"who":[62,71],"had":[63,157,188],"monotherapy":[65,156,247],"as":[66],"their":[67],"first":[68],"treatment":[69],"and":[70,118,139,177,199,213],"then":[72],"initiated":[73],"on":[74],"relevant":[75],"regimens":[78,218],"during":[79],"period":[82],"2000-2010.":[83],"A":[84],"total":[85],"27,457":[87],"prescribed":[90,99],"second-line":[92],"therapy,":[93],"whom":[95],"26,278":[96],"(95.7%)":[97],"regimen":[101],"1,000":[103],"or":[104],"more":[105],"observations.":[106],"MAIN":[107],"OUTCOME":[108],"MEASURES:":[109],"All-cause":[110],"mortality,":[111],"major":[112],"adverse":[113],"cardiovascular":[114],"events":[115],"(MACE),":[116],"cancer,":[117],"combined":[120,179,201],"end":[121,130,145,180,202],"point":[122,181,203],"any":[124],"these":[126],"measured.":[128],"Secondary":[129],"points":[131,146],"change":[133],"in":[134,249],"glycosylated":[135,208],"hemoglobin":[136,209],"between":[137,211],"baseline":[138,212],"12":[140,214],"months.":[141],"Time":[142],"compared":[148,236],"Cox":[150],"proportional":[151],"hazards":[152],"models.":[153],"RESULTS:":[154],"Sulfonylurea":[155,246],"significantly":[158,189],"higher":[159],"hazard":[160],"ratios":[161],"(HRs)":[162],"for":[163,193,216],"all-cause":[164,194],"mortality":[165,195],"(HR":[166,170,174,182,196,204],"1.459,":[167],"1.207-1.763);":[168],"MACE":[169],"1.578,":[171],"1.187-2.099);":[172],"stroke":[173],"1.444,":[175],"1.050-1.987);":[176],"1.381,":[183],"1.194-1.597).":[184],"Metformin":[185],"plus":[186,228,244],"pioglitazone":[187,229],"lower":[190],"adjusted":[191],"HRs":[192],"0.707,":[197],"0.515-0.970)":[198],"0.747,":[205],"0.612-0.911).":[206],"Mean":[207],"improved":[210],"months":[215],"all":[217],"other":[219],"than":[220],"sulfonylurea":[221],"monotherapy.":[222],"CONCLUSION:":[223],"combination":[225],"appears":[230],"provide":[232],"superior":[233],"most":[239],"commonly":[240],"used":[241],"regimen,":[242],"sulfonylurea.":[245],"resulted":[248],"worse":[250],"outcome.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2029477388","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
